[Chronic diarrhea in 43-year-old man].

Rev Med Interne

Service de médecine interne, centre hospitalier de Béziers, ZAC de Montimaran, 2, rue Valentin-Haüy, BP 740, 34525 Béziers, France.

Published: December 2013

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.revmed.2013.06.010DOI Listing

Publication Analysis

Top Keywords

[chronic diarrhea
4
diarrhea 43-year-old
4
43-year-old man]
4
[chronic
1
43-year-old
1
man]
1

Similar Publications

Current treatments for persistent or chronic immune thrombocytopenia (ITP) are limited by inadequate response, toxicity, and impaired quality of life. The Bruton tyrosine kinase inhibitor rilzabrutinib was evaluated to further characterize safety and durability of platelet response. LUNA2 Part B is a multicenter, phase 1/2 study in adults with ITP (≥ 3 months duration, platelet count < 30 × 10/L) who failed ≥ 1 ITP therapy (NCT03395210, EudraCT 2017-004012-19).

View Article and Find Full Text PDF

Objective: Explore the nature and prevalence of long-term conditions in individuals with intellectual disability.

Design: Retrospective longitudinal population-based study.

Setting: Primary and secondary care data across the population of Wales with the Secure Anonymised Information Linkage (SAIL) Databank.

View Article and Find Full Text PDF

Histoplasmosis is a rarely reported clinical disease of equids in North America and is historically attributed to Histoplasma capsulatum var. capsulatum. This report details a case of intestinal histoplasmosis with lymphadenitis in an American Mammoth Jackstock donkey from Mississippi.

View Article and Find Full Text PDF

Objectives: Bile acid diarrhea is a common but underdiagnosed condition. Because the gold standard test (SeHCAT) is time-consuming and not widely available, fecal bile acid excretion is typically assessed by chromatography and mass spectrometry. Although enzymatic cycling assays are well established for the rapid and cost-effective analysis of total bile acids (TBA) in serum or plasma, their full potential has yet not been extended to stool samples in clinical routine.

View Article and Find Full Text PDF

Background: The study aimed to comprehensively analyze and establish a framework for evaluating the efficacy of microbiome-targeted treatment (MTT) for depression.

Methods: We searched PubMed, Embase, Cochrane Library, Web of Science, and the Chinese National Knowledge Infrastructure database for randomized controlled trials (RCTs) on MTT in treating depression until October 19, 2023. A meta-analysis was conducted to evaluate the efficacy and safety of MTT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!